| Description |
Featuring:
Abgenix, Inc.
ArQule, Inc.
Aventis Pharma
Banc America Securities LLC
BioScience Valuation BSV
GmbH
Bristol-Myers Squibb
Eli Lilly & Company
Hoffmann-La Roche
Immusol, Inc.
Legg Mason
Mayer Brown Rowe & Mawe
Mehta Partners
Merck & Company
Novartis Pharmaceuticals
Paul Capital Partners
Pfizer, Inc.
Pharmacia Corporation
QED Technologies
QLT, Inc.
State Street Research & Management
Wyeth Pharmaceuticals
ZymoGenetics, Inc.
Presenting:
Deals 2002: Bigger, Better, LFaster
LEGG MASON WOOD WALKER
Biotech M&A: What Can Be Expected
MEHTA PARNTERS
Are the Right Deals Getting Done? - An Investor's Perspective
STATE STREET RESEARCH & MANAGEMENT
A View from Wall Street: Antibody Therapeutics
BANC AMERICA SECURITIES LLC
Big Pharma Showcase - Nine Talks on Business Development
*Immusol's $150mm Oncology Alliance with Novartis
*The Lilly-Isis Partnership in Antisense
*The ZymoGenetic - Serono Deal in Cancer & Immunotherapies
*Evolution of Antibody Licensing Deals - Abgenix, Inc.
*Why Biotech May Be a Better Partner than Big Pharma: The QLT, Inc. - Xenova $52.5mm Deal
|
|
